These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18698675)

  • 21. Therapy with stem cells in inflammatory bowel disease.
    Martínez-Montiel Mdel P; Gómez-Gómez GJ; Flores AI
    World J Gastroenterol; 2014 Feb; 20(5):1211-27. PubMed ID: 24574796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges.
    Eiro N; Fraile M; González-Jubete A; González LO; Vizoso FJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of adipose stem cells in inflammatory bowel disease: From biology to novel therapeutic strategies.
    De Francesco F; Romano M; Zarantonello L; Ruffolo C; Neri D; Bassi N; Giordano A; Zanus G; Ferraro GA; Cillo U
    Cancer Biol Ther; 2016 Sep; 17(9):889-98. PubMed ID: 27414952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up].
    Knyazev OV; Parfenov AI; Konoplyannikov AG; Ruchkina IN; Churikova AA; Bykova SV; Albulova EA; Boldyreva ON; Fadeeva NA; Lishchinskaya AA
    Ter Arkh; 2015; 87(2):39-44. PubMed ID: 25864347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells.
    Huldani H; Margiana R; Ahmad F; Opulencia MJC; Ansari MJ; Bokov DO; Abdullaeva NN; Siahmansouri H
    Int Immunopharmacol; 2022 Jun; 107():108698. PubMed ID: 35306284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.
    Saadh MJ; Mikhailova MV; Rasoolzadegan S; Falaki M; Akhavanfar R; Gonzáles JLA; Rigi A; Kiasari BA
    Eur J Med Res; 2023 Jan; 28(1):47. PubMed ID: 36707899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
    Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
    Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of the International Society for Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).
    Ciccocioppo R; Baumgart DC; Dos Santos CC; Galipeau J; Klersy C; Orlando G
    Cytotherapy; 2019 Aug; 21(8):824-839. PubMed ID: 31201092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges.
    Tian CM; Zhang Y; Yang MF; Xu HM; Zhu MZ; Yao J; Wang LS; Liang YJ; Li DF
    J Inflamm Res; 2023; 16():2089-2119. PubMed ID: 37215379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
    Dharmani P; Chadee K
    Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?
    Hawkey CJ; Hommes DW
    Gastroenterology; 2017 Feb; 152(2):389-397.e2. PubMed ID: 27845055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary causes of inflammatory bowel diseases.
    Ghouri YA; Tahan V; Shen B
    World J Gastroenterol; 2020 Jul; 26(28):3998-4017. PubMed ID: 32821067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis.
    Pouya S; Heidari M; Baghaei K; Asadzadeh Aghdaei H; Moradi A; Namaki S; Zali MR; Hashemi SM
    Int Immunopharmacol; 2018 Jan; 54():86-94. PubMed ID: 29112894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD.
    Ricart E
    Dig Dis; 2012; 30(4):387-91. PubMed ID: 22796802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease.
    El-Matary W
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.